切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 419 -425. doi: 10.3877/cma.j.issn.1674-134X.2019.04.006

所属专题: 文献

临床论著

活动期类风湿关节炎行膝关节置换的安全性与有效性
甄平1,(), 李旭升1, 周胜虎1, 刘军1   
  1. 1. 730050 兰州,解放军联勤保障部队第940医院(原兰州军区总医院)骨科中心关节外科
  • 收稿日期:2017-06-27 出版日期:2019-08-01
  • 通信作者: 甄平
  • 基金资助:
    国家自然科学基金(81371983); 甘肃省青年科技基金(18JR3RA410)

Safety and efficacy of total knee arthroplasty in treatment of active rheumatoid arthritis

Ping Zhen1,(), Xusheng Li1, Shenghu Zhou1, Jun Liu1   

  1. 1. Department of Orthopaedic, The General Hospital of PLA, Lanzhou 730050, China
  • Received:2017-06-27 Published:2019-08-01
  • Corresponding author: Ping Zhen
  • About author:
    Corresponding author: Zhen Ping, Email:
引用本文:

甄平, 李旭升, 周胜虎, 刘军. 活动期类风湿关节炎行膝关节置换的安全性与有效性[J]. 中华关节外科杂志(电子版), 2019, 13(04): 419-425.

Ping Zhen, Xusheng Li, Shenghu Zhou, Jun Liu. Safety and efficacy of total knee arthroplasty in treatment of active rheumatoid arthritis[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2019, 13(04): 419-425.

目的

探讨活动期类风湿性关节炎进行膝关节置换手术(TKA)的安全性与有效性。

方法

2010年10月至2015年3月兰州军区总医院对35例(45膝)活动期类风湿性膝关节炎的患者进行人工膝关节置换手术,男10例(10膝),女25例(35膝);平均年龄(55±9)岁。排除全身发热、不耐受手术者。分别在手术治疗前、治疗后1年和2年检测类风湿因子、红细胞沉降率和C-反应蛋白水平,膝关节功能评定采用美国膝关节协会(KSS)关节功能评分标准。记录膝关节置换术后关节疼痛肿胀以及术后并发症情况。应用SPSS 21. 0统计学软件对数据进行统计学分析,采用配对样本t检验比较手术治疗前后膝关节功能和生化指标变化情况。

结果

本组35例(45膝)均获得随访,随访时间(4.2±1.6)年。膝关节置换术后2年类风湿因子、红细胞沉降率和C-反应蛋白水平与手术前相比有明显下降,差异有统计学意义。膝关节活动度由术前(53±13)°(42°~67°)术后提高至末次随访时的(93±11)°(82°~104°),差异有统计学意义(t=27.461,P<0.01);膝关节KSS评分从术前平均(56±10)分提高至末次随访时平均(88±8)分,差异有统计学意义(t=68.731,P<0.01)。术后受累关节类风湿关节炎症状均显著改善,主要表现在疼痛、肿胀和主观感受等方面。随访期间无伤口裂开、延期愈合、感染以及假体松动的发生,1例术后第3天进行膝关节屈伸功能锻炼时发生股骨远端假体周围骨折,行切开复位钢板内固定。

结论

活动期类风湿性关节炎行TKA手术安全可靠,正确的围手术期评估与干预、有效的膝关节病变滑膜切除、精准的手术操作可有效降低TKA外科治疗风险。

Objective

To evaluate the safety and efficacy of total knee arthroplasty in treatment of rheumatoid arthritis in active stage.

Methods

Thirty-five patients (45 knees) with rheumatoid arthritis in active stage had undergone total knee arthroplasty (TKA) in Lanzhou Ganeral Hospital of PLA with at least two years follow-up from October 2010 to March 2015. There were 10 men (10 knees) and 25 women (35 knees), with an average age of (55±9) years. The patients with fever whocouldnot accepte operation were excluded. The rheumatoid factor, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels of the patients were measured before treatment, one and two years after TKA treatment, and the KSS joint function scoring criteria was used to assess the functions. The symptoms and complications were also recorded. The data were statistically analyzed by SPSS 21.0 statistical software with pair-t test to compare the rheumatoid factor, ESR and CRP levels, so as the knee functions.

Results

All the patients were followed up for average (4.2±1.6)years. Two years after TKA treatment, the indicators (rheumatoid factor, ESR, CRP) at two years after TKA treatment were significantly lower than those before treatment (P <0.01). All the functions of the knee joint were improved after TKA.The range of knee motion was improved from (53±13)°(42°-67°) to preoperative (93±11)° (82°-104°) at two years fellow up (t=27.461, P <0.01). The KSS knee score was improved from the preoperative (56±10) to the (88±8) at the last follow-up examination, and there was statistical difference between preoperative results and the results of the latest follow-up (t =68.731, P <0.01). No patients suffered wound dehiscence, delayed healing, infection and prosthesis loosening in follow-up.

Conclusion

TKA is safety and efficacy in treating the RA patients with active stage. Detailed evaluation and multidisciplinary cooperation at perioperative period, effective synovectomy of knee and correct TKA manipulation are necessary to reduce the risk of TKA surgery.

图2 截骨断面严重骨质疏松
图3 双膝活动期类风湿性关节炎行全膝关节置换术前后X线正位片。图A为术前双膝正位X线片,示双膝外翻畸形,关节间隙消失,局部严重骨质疏松;图B为术后双下肢全长正位X线片,示髋-膝-踝角左侧178°(角偏差2°),右侧179 °(角偏差1°)
[1]
Norton S, Fu B, Scott DL, et al. Health assessment questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts[J]. Semin Arthritis Rheum, 2014, 44(2): 131-144.
[2]
Zwartelé RE, Witjes S, Doets HC, et al. Cementless total hip arthroplasty in rheumatoid arthritis: a systematic review of the literature[J]. Arch Orthop Trauma Surg, 2012, 132(4): 535-546.
[3]
Jain A, Stein BE, Skolasky RL,et al. Total joint arthroplasty in patients with rheumatoid arthritis a United States experience from 1992 through 2005[J]. J Arthroplasty,2012,27(6):881-888.
[4]
Trieb K, Schmid M, Stulnig T, et al. Long-term outcome of total knee replacement in patients with rheumatoid arthritis[J]. Joint Bone Spine, 2008, 75(2): 163-166.
[5]
Nakamura H, Tanaka H, Yoshino S. Long-term results of multiple synovectomy for patients with refractory rheumatoid arthritis. Effects on disease activity and radiological progression[J]. Clin Exp Rheumatol, 2004, 22(2): 151-157.
[6]
Nakamura H, Nagashima M, Ishigami S, et al. The anti-rheumatic effect of multiple synovectomy in patients with refractory rheumatoid arthritis [J]. Int Orthop, 2000, 24(5): 242-245.
[7]
Yano K, Ikari K, Inoue E, et al. Effect of total knee arthroplasty on disease activity in patients with established rheumatoid arthritis: 3-year follow-up results of combined medical therapy and surgical intervention[J]. Mod Rheumatol,2010, 20(5):452-457.
[8]
Momohara S, Inoue E, Ikari K,et al. Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life[J]. Mod Rheumatol. 2011, 21(5):476-481.
[9]
Au K, Reed G, Curtis JR, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis [J]. Ann Rheum Dis, 2011, 70(5): 785-791.
[10]
Provan SA, Semb AG, Hisdal J, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study[J]. Ann Rheum Dis, 2011, 70(5): 812-817.
[11]
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Arthritis Rheum,2010, 62(9):2569-2581.
[12]
Prevoo ML, Van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[J]. Arthritis Rheum, 1995, 38(1): 44-48.
[13]
Anderson J, Caplan L, Yazdany J, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice[J]. Arthritis Care Res (Hoboken), 2012, 64(5): 640-647.
[14]
Peters MJ, Symmons DP, Mccarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis[J]. Ann Rheum Dis, 2010, 69(2): 325-331.
[15]
Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study[J]. Arthritis Rheum, 2010, 62(6): 1583-1591.
[16]
Kheansaard W, Mas-Oo-Di S, Nilganuwong SA. Interferon-gamma induced nitric oxide-mediated apoptosis of anemia of chronic disease in rheumatoid arthritis[J]. Rheumatol Int, 2013, 33(1): 151-156.
[17]
Goodman SM, Springer B, Guyatt G, et al. 2017 American College of Rheumatology/American Association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty[J].J Arthroplasty. 2017, 32(9):2628-2638.
[18]
翟吉良,翁习生,林进,等.术前ESR和CRP在类风湿性关节炎膝关节置换术中的价值[J].实用骨科杂志,2014,20(2):130-132.
[19]
Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative[J]. Ann Rheum Dis,2009, 68(7):1086-1093.
[20]
Li L, Zhu Z, Chen J, et al. Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis[J]. Am J Med Sci, 2013,345(3):178-184.
[21]
边焱焱,翁习生,林进,等.多关节置换治疗晚期下肢关节疾患[J].中国修复重建外科杂志,2012,26(3):296-299.
[22]
Tanaka N, Sakahashi H, Sato E, et al. Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis[J]. J Clin Rheumatol. 2003,9(2):115-118.
[23]
罗福昌,邱华文,王一民,等.C反应蛋白增高患者行髋关节置换术后临床疗效观察[J].中国骨与关节损伤杂志[J],2014,29(8):751-752.
[24]
甄平,李慎松,李旭升,等.晚期类风湿性关节炎合并屈膝位强直的人工全膝关节置换术[J].中国骨伤,2015,28(3):272-275.
[25]
Parvizi J, Hanssen AD, Spangehl MJ. Total knee arthroplasty following proximal tibial osteotomy: risk factors for failure [J]. J Bone Joint Surg Am, 2004, 86(3):474-479.
[26]
周程沛,周宗科,沈彬,等.膝关节类风湿关节炎伴重度屈曲畸形患者关节置换术后的中长期随访[J/CD].中华关节外科杂志(电子版),2012,6(5):689-694.
[27]
Scudefi GR, Clarke HD. Cemented posterior stabilized total knee arthroplasty[J]. J Arthroplasty, 2004, 19(1): 17-21.
[28]
Laskin RS, O'flynn HM. Total knee replacement with posterior cruciate ligament retention in rheumatoid arthritis-problems and complications[J]. Clin Orthop Relat Res, 1997,(345): 24-28.
[29]
Roux C. Osteoporosis in inflammatory joint diseases [J]. Osteoporos Int, 2011, 22(2):421-433.
[30]
计忠伟,包倪荣,赵建宁.膝关节骨性关节炎与类风湿性关节炎患者骨小梁的显微结构分析[J].中国矫形外科杂志,2015,23(5):388-392.
[31]
吴立新,张海彬,李晓辉,等. 全膝关节置换后类风湿关节炎生化指标及受累关节功能变化[J]. 中国组织工程研究,2013, 17(39): 6896-6901.
[1] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[2] 刘骏, 朱霁, 殷骏. 右美托咪定对腹股沟疝手术麻醉效果及安全性的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 570-573.
[3] 彭永辉, 张文杰, 李炳根, 聂向阳, 吴凯, 杨六成. 单孔双针疝囊高位结扎术在儿童巨大腹股沟疝的临床应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 566-569.
[4] 路东明, 陈建华, 艾月琴. 布地格福吸入气雾剂治疗支气管哮喘的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 361-363.
[5] 王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[6] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[7] 范清泉, 宋晓玲, 翁明哲, 顾钧. 消化道重建术后ERCP安全性和疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 331-335.
[8] 黄洁. 腹腔镜肝脏手术中一些值得深入思考的问题[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 267-271.
[9] 娜荷雅, 朱丹. 红光疗法在儿童近视眼防控中的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 252-256.
[10] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[11] 陈婷婷, 江学良, 余佳丽, 柯剑林. 干细胞治疗炎症性肠病的安全性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 193-198.
[12] 朴成林, 蓝炘, 司振铎, 冯健, 安峰铎, 李强, 谈明坤, 赵娜, 冷建军. 局部晚期右半结肠癌行结肠癌根治联合胰十二指肠切除术疗效分析:附5例报告[J]. 中华临床医师杂志(电子版), 2023, 17(06): 666-670.
[13] 曹文玺, 陈箫, 竺来法, 周永平. 尼妥珠单抗联合白蛋白结合型紫杉醇治疗胰腺癌的有效性及安全性分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 409-413.
[14] 梁君, 褚晨宇, 孙凤艳, 袁仪浪, 周曦, 王卫东. 胸壁完全植入式静脉输液港术中隧道针逆向穿刺的可行性和安全性[J]. 中华介入放射学电子杂志, 2023, 11(04): 310-313.
[15] 黄学卿, 魏楠, 蒋天鹏, 安天志, 王黎洲, 许敏, 周石. 超声引导经远端桡动脉入路行肝癌TACE术的临床研究[J]. 中华介入放射学电子杂志, 2023, 11(03): 251-256.
阅读次数
全文


摘要